The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Discovery of simplified leucyladenylate sulfamates as novel leucyl-tRNA synthetase (LRS)-targeted mammalian target of rapamycin complex 1 (mTORC1) inhibitors
Abstract
Leucyl-tRNA synthetase (LRS) has been reported to be a possible mediator of intracellular amino acids signaling to mTORC1. Given that mTORC1 is associated with cell proliferation and tumorigenesis, the LRS-mediated mTORC1 pathway may offer an alternative strategy in anticancer therapy. In this study, we developed a series of simplified analogues of leucyladenylate sulfamate (1) as LRS-targeted mTORC1 inhibitors. We replaced the adenylate group with a N-(3,4-dimethoxybenzyl)benzenesulfonamide (2a) or a N-(2-phenoxyethyl)benzenesulfonamide groups (2b) that can maintain specific binding, but has more favorable physicochemical properties such as reduced polarity and asymmetric centers. Among these simplified analogues, compound 16 and its constrained analogue 22 effectively inhibited S6K phosphorylation in a dose-dependent manner and exhibited cancer cell specific cytotoxicity against six different types of cancer cells. This result supports that LRS is a viable target for novel anticancer therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The leucyl-tRNA synthetase (LRS) has been proposed to function as a leucine sensor for mTORC1, acting as a GAP for RagD, and several recent compounds, e.g. (S)-4-isobutyloxazolidin-2-one and BC-LI-0186, have been identified that inhibit mTORC1 by interfering with LRS sensing or activity 178,183–186.”
From Targeting the biology of aging with mTOR inhibitors (2023) · cites this paper as [185]
Citations
Cites
mTOR and cancer: insights into a complex relationship
Sabatini, D. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1974 · Cited by 1,322
Research works printed but not linked: 20
- Laplante, 2012, Cell, 149, 274, 10.1016/j.cell.2012.03.017 · DOI · Paper page
- Bjornsti, 2004, Nat Rev Cancer, 4, 335, 10.1038/nrc1362 · DOI
- Benjamin, 2011, Nat Rev Drug Discov, 10, 868, 10.1038/nrd3531 · DOI
- Chiang, 2007, Trends Mol Med, 13, 433, 10.1016/j.molmed.2007.08.001 · DOI
- Guertin, 2007, Cancer Cell, 12, 9, 10.1016/j.ccr.2007.05.008 · DOI · Paper page
- Hudes, 2007, N Engl J Med, 356, 2271, 10.1056/NEJMoa066838 · DOI
- Motzer, 2008, Lancet, 372, 449, 10.1016/S0140-6736(08)61039-9 · DOI · Paper page
- Thoreen, 2009, Autophagy, 5, 725, 10.4161/auto.5.5.8504 · DOI
- Chiarini, 2015, Trends Pharmacol Sci, 36, 124, 10.1016/j.tips.2014.11.004 · DOI
- Strimpakos, 2009, Cancer Treat Rev, 35, 148, 10.1016/j.ctrv.2008.09.006 · DOI
- Stipanuk, 2007, Nutr Rev, 65, 122, 10.1111/j.1753-4887.2007.tb00289.x · DOI
- Dodd, 2012, Am J Physiol Endocrinol Metab, 302, E1329, 10.1152/ajpendo.00525.2011 · DOI
- Han, 2012, Cell, 149, 410, 10.1016/j.cell.2012.02.044 · DOI · Paper page
- Bonfils, 2012, Mol Cell, 46, 105, 10.1016/j.molcel.2012.02.009 · DOI
- Lynch, 2000, J Cell Biochem, 77, 234, 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I · DOI
- Wang, 2008, J Biol Chem, 283, 30482, 10.1074/jbc.M803348200 · DOI
- Yoon, 2016, J Med Chem, 59, 10322, 10.1021/acs.jmedchem.6b01190 · DOI · Paper page
- Yoon, 2016, Bioorg Med Chem Lett, 26, 3038, 10.1016/j.bmcl.2016.05.011 · DOI · Paper page
- Filippov, 1998, Tetrahedron Lett, 39, 4891, 10.1016/S0040-4039(98)00888-0 · DOI
- Vichai, 2006, Nat Protoc, 1, 1112, 10.1038/nprot.2006.179 · DOI
Cited by
Sorted by citations
Targeting the biology of aging with mTOR inhibitors
Mannick, J. B., & Lamming, D. W. (2023) · Nature Aging · doi:10.1038/s43587-023-00416-y · Cited by 372
Metadata
- Authors
- Yoon, S., Kim, J. H., Koh, Y., Tran, P.-T., Ann, J., Yoon, I., Jang, J., Kim, W. K., Lee, S., Lee, J., Kim, S., & Lee, J.
- ORCID
- Kim, Jong Hyun
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 25
- Issue
- 15
- Pages
- 4145-4152
- ISSN
- 0968-0896
- Cited by
- 15
- References
- 1
- Language
- en
- Funders
- Ministry of Education, Science and Technology of Korea (NRF-2012M3A6A4054928)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review